|
![]() |
|||
|
||||
OverviewExamines the entire pharmaceutical development process, emphasizing approaches to increasing efficiency and reducing costs. Challenges current avenues of drug development used by industry and regulatory agencies and presents alternatives that seek to improve outdated processes. Full Product DetailsAuthor: Peter Welling (Kent) , Louis Lasagna , Umesh V. BanakerPublisher: Taylor & Francis Inc Imprint: Marcel Dekker Inc Volume: v. 76 Dimensions: Width: 15.20cm , Height: 2.70cm , Length: 22.90cm Weight: 0.771kg ISBN: 9780824797270ISBN 10: 0824797272 Pages: 472 Publication Date: 15 August 1996 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Out of Stock Indefinitely Availability: Awaiting stock ![]() Table of ContentsReviewsPresentations considering legal issues and their relationship to cost effectiveness, opportunities for optimal use of contract research reorganization, and foreign drug development achievements are highlights of the book. -Journal of Medicinal Chemistry From the Foreword The authorsin this book have thought and written about a variety of subjects that need to be considered in re-engineering, the drug development process to meet the challenges of the future. This book gives the readers the opportunity to think with these experts as they address specific problems faced by readers in trying to increase the efficiency and effectiveness of their part of the drug development process. -Marcus M. Reidenberg. M.D., Departments of Pharmacology and Medicine, Cornell University Medical College, NY, NY Author InformationTab Content 6Author Website:Countries AvailableAll regions |